Related Experiment Video
Updated: Aug 7, 2026
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
Clinical characteristics and risk factors in patients with colon cancer liver metastases
1Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, China.
Background:
Liver metastases (LM) are clinically important in colon cancer, but routinely available clinicopathological and laboratory profiles associated with LM status remain incompletely characterized. This study aimed to identify clinical, pathological, and laboratory variables associated with LM status in patients with colon cancer.
Methods:
This retrospective observational study included patients with pathologically confirmed colon cancer diagnosed between January 2020 and December 2023. LM was identified by imaging and/or histopathological confirmation. A pragmatic 1:2 non-propensity-score matching strategy was used to select non-LM controls. Univariable and multivariable logistic regression analyses were performed to evaluate variables associated with LM status. Sensitivity analyses and exploratory subgroup analyses of synchronous and metachronous LM were conducted.
Results:
Among 756 eligible patients, 101 developed LM, yielding an incidence of 13.4%. The matched cohort included 101 LM patients and 202 controls. After adjustment, lymphovascular invasion (adjusted odds ratio [aOR] 2.57, 95% confidence interval [CI] 1.38-4.76; P = 0.003), perineural invasion (aOR 1.94, 95% CI 1.05-3.59; P = 0.035), N2 stage (aOR 2.48, 95% CI 1.17-5.25; P = 0.018), carcinoembryonic antigen (CEA) per doubling (aOR 1.72, 95% CI 1.42-2.10; P<0.001), and neutrophil-to-lymphocyte ratio (NLR) per 1-unit increase (aOR 1.35, 95% CI 1.15-1.59; P<0.001) were independently associated with LM status. Sensitivity analyses showed generally consistent findings. Synchronous LM was characterized by higher carcinoembryonic antigen and NLR levels than metachronous LM.
Conclusions:
LM status in colon cancer was associated with adverse pathological features, nodal burden, higher CEA levels, and higher NLR. These routinely available variables may serve as supportive clinical indicators for assessing hepatic involvement, but should not be interpreted as causal factors or as a validated prediction model.
More Related Videos
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...